imedpharma, Author at iMedPharma.com

I-MED Pharma Partners with Iogen Oy to Introduce I-DROP®, I-LID ’N LASH®, I-RELIEFTM Therapeutic Eye Mask and the I-PEN® Osmolarity System to the Finnish Market.

October 31, 2018
Press Releases

MONTREAL, November 1st, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive distribution agreement with Iogen Oy for its I-DROP® and I-LID ’N…

I-MED Pharma Partners with Quidel to Introduce I-LID ’N LASH®, I-RELIEF® and SMTube® to the U.S Market.

October 17, 2018
Press Releases

I-MED Pharma Partners with Quidel to Introduce I-LID ’N LASH®, I-RELIEF® and SMTube® to the U.S Market. MONTREAL, October 17, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to…

I-MED Pharma’s I-PEN® Does Not Infringe the TearLab Patent

February 22, 2018
Press Releases

Montreal, February 20, 2018 (GLOBE NEWSWIRE) – On February 14th TearLab issued a press release indicating it will appeal after its defeat in a patent infringement action against I-MED Pharma Inc. in Canada. In the press release, it was stated…

I-MED PHARMA Inc. Website Announcement

February 13, 2018
Animal Health, Diagnostic Tools, Dry Eye Products, Events, I-Pen

I-MED PHARMA Inc., Your Leader in Ocular Surface Disorder Management, is proud to announce the launch of our new and improved website www.imedpharma.com. This site contains a comprehensive list of all our OSD, diagnostic and surgical product offerings detailing their…

I-MED Pharma Wins Patent Case Against TearLab

February 13, 2018
Press Releases

Montreal, February 13, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., announced today that TearLab’s efforts to keep the I-PEN® Osmolarity System off the market proved unsuccessful. I-MED Pharma wins patent case against TearLab, with costs awarded to I-MED. In February…